Detalhe da pesquisa
1.
Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation.
Circulation
; 147(7): 575-585, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780380
2.
Sex-associated differences in cardiac ageing: Clinical aspects and molecular mechanisms.
Eur J Clin Invest
; : e14215, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38624065
3.
Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study.
Am Heart J
; 264: 72-82, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279839
4.
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment.
Semin Thromb Hemost
; 49(8): 816-832, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223804
5.
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.
Circulation
; 140(23): 1904-1916, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553204
6.
Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot.
Eur Heart J
; 44(3): 236, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36303423
7.
Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: A randomized clinical trial.
Am Heart J
; 204: 205-209, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30149889
8.
TIcaGrEloR and Absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization (TIGER-BVS trial): Rationale and study design.
Catheter Cardiovasc Interv
; 91(1): 1-6, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28707316
9.
Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention.
Eur Heart J
; 43(33): 3115-3117, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861271
10.
Rationale and design of the Hunting for the off-target propertIes of Ticagrelor on Endothelial function and other Circulating biomarkers in Humans (HI-TECH) trial.
Am Heart J
; 189: 128-136, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28625369
11.
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.
Catheter Cardiovasc Interv
; 89(5): 812-818, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515568
12.
Response by Ortega-Paz et al to Letter Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".
Circulation
; 141(15): e748-e749, 2020 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32282250
13.
Very-late restenosis of a magnesium-based resorbable scaffold.
Eur Heart J
; 41(27): 2602, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32458000
14.
Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea.
Circulation
; 138(6): 646-648, 2018 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29794083
15.
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Thromb Haemost
; 124(3): 263-273, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224883
16.
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial.
Rev Esp Cardiol (Engl Ed)
; 77(3): 215-225, 2024 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-37506972
17.
Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography.
Cardiovasc Revasc Med
; 60: 18-26, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793964
18.
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score.
J Am Coll Cardiol
; 83(15): 1370-1381, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599713
19.
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome.
J Clin Med
; 13(7)2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610650
20.
P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC-2 Study.
JACC Cardiovasc Interv
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597172